These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38083484)

  • 21. Magnetic resonance imaging and transient elastography in the management of Nonalcoholic Fatty Liver Disease (NAFLD).
    Han MA; Saouaf R; Ayoub W; Todo T; Mena E; Noureddin M
    Expert Rev Clin Pharmacol; 2017 Apr; 10(4):379-390. PubMed ID: 28277807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic Resonance Imaging-Proton Density Fat Fraction vs. Transient Elastography-Controlled Attenuation Parameter in Diagnosing Non-alcoholic Fatty Liver Disease in Children and Adolescents: A Meta-Analysis of Diagnostic Accuracy.
    Jia S; Zhao Y; Liu J; Guo X; Chen M; Zhou S; Zhou J
    Front Pediatr; 2021; 9():784221. PubMed ID: 35087774
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of Magnetic Resonance-Based Elastography and Ultrasound Shear Wave Elastography in Patients With Suspicion of Nonalcoholic Fatty Liver Disease.
    Tahmasebi A; Wessner CE; Guglielmo FF; Wang S; Vu T; Liu JB; Civan J; Lyshchik A; Forsberg F; Li H; Qu E; Eisenbrey JR
    Ultrasound Q; 2023 Jun; 39(2):100-108. PubMed ID: 36943721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of Controlled Attenuation Parameter in Detecting and Monitoring Hepatic Steatosis with MRI-PDFF as Reference.
    Wang JH; Ou HY; Yen YH; Chen CH; Lu SN
    Dig Dis Sci; 2020 May; 65(5):1512-1519. PubMed ID: 31617130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic Resonance-Based Assessments Better Capture Pathophysiologic Profiles and Progression in Nonalcoholic Fatty Liver Disease.
    Choi SJ; Kim SM; Kim YS; Kwon OS; Shin SK; Kim KK; Lee K; Park IB; Choi CS; Chung DH; Jung J; Paek M; Lee DH
    Diabetes Metab J; 2021 Sep; 45(5):739-752. PubMed ID: 33108854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib.
    Jayakumar S; Middleton MS; Lawitz EJ; Mantry PS; Caldwell SH; Arnold H; Mae Diehl A; Ghalib R; Elkhashab M; Abdelmalek MF; Kowdley KV; Stephen Djedjos C; Xu R; Han L; Mani Subramanian G; Myers RP; Goodman ZD; Afdhal NH; Charlton MR; Sirlin CB; Loomba R
    J Hepatol; 2019 Jan; 70(1):133-141. PubMed ID: 30291868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decision analytic model of the diagnostic pathways for patients with suspected non-alcoholic fatty liver disease using non-invasive transient elastography and multiparametric magnetic resonance imaging.
    Blake L; Duarte RV; Cummins C
    BMJ Open; 2016 Sep; 6(9):e010507. PubMed ID: 27650757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence of nonalcoholic fatty liver disease in Chinese adults screened by vibration controlled transient elastography and its diagnostic discrepancy compared with ultrasound.
    Ding Y; Jiang L; Wang Q; Zhao W; Zhou X; Lu J; Tian T; Yu C; Xu X; Guo W; Zhang Q; Song C
    Clin Res Hepatol Gastroenterol; 2022 Oct; 46(8):101951. PubMed ID: 35605893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MR Spectroscopy-derived Proton Density Fat Fraction Is Superior to Controlled Attenuation Parameter for Detecting and Grading Hepatic Steatosis.
    Runge JH; Smits LP; Verheij J; Depla A; Kuiken SD; Baak BC; Nederveen AJ; Beuers U; Stoker J
    Radiology; 2018 Feb; 286(2):547-556. PubMed ID: 28915103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlled attenuation parameter in the diagnosis of different liver steatosis groups in children with obesity.
    Yang L; Lin Y; Zhu YF; Zhu YY; Liang ZM; Wu GS
    Pediatr Obes; 2022 Jun; 17(6):e12893. PubMed ID: 35092183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnetic resonance imaging improves stratification of fibrosis and steatosis in patients with chronic liver disease.
    Lee HA; Kim SS; Choi JY; Seo YS; Park BJ; Sim KC; Kim SU
    Abdom Radiol (NY); 2022 Nov; 47(11):3733-3745. PubMed ID: 35962809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for undiagnosed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A population-based risk factor assessment using vibration controlled transient elastography (VCTE).
    Eskridge W; Vierling JM; Gosbee W; Wan GA; Hyunh ML; Chang HE
    PLoS One; 2021; 16(11):e0260320. PubMed ID: 34847156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-Invasive Approaches to Estimate Liver Steatosis and Stiffness in Children With Non-Alcoholic Fatty Liver Disease.
    Yodoshi T; Orkin S; Trout AT; Arce-Clachar AC; Bramlage K; Liu C; Fei L; Dillman JR; Xanthakos SA; Mouzaki M
    J Pediatr Gastroenterol Nutr; 2022 Apr; 74(4):495-502. PubMed ID: 34908012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening HIV Patients at Risk for NAFLD Using MRI-PDFF and Transient Elastography: A European Multicenter Prospective Study.
    Lemoine M; Assoumou L; Girard PM; Valantin MA; Katlama C; De Wit S; Campa P; Rougier H; Meynard JL; Necsoi C; Huefner AD; Van Luzen J; Schulze Zur Wiesch J; Bastard JP; Fellahi S; Mauss S; Stankov MV; Baumgarten A; Post G; Serfaty L; Ratziu V; Menu Y; Schlue J; Bedossa P; Capeau J; Costagliola D; Behrens G; Ingiliz P;
    Clin Gastroenterol Hepatol; 2023 Mar; 21(3):713-722.e3. PubMed ID: 35436624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocol.
    Pavlides M; Mózes FE; Akhtar S; Wonders K; Cobbold J; Tunnicliffe EM; Allison M; Godfrey EM; Aithal GP; Francis S; Romero-Gomez M; Castell J; Fernandez-Lizaranzu I; Aller R; González RS; Agustin S; Pericàs JM; Boursier J; Aube C; Ratziu V; Wagner M; Petta S; Antonucci M; Bugianesi E; Faletti R; Miele L; Geier A; Schattenberg JM; Tilman E; Ekstedt M; Lundberg P; Berzigotti A; Huber AT; Papatheodoridis G; Yki-Järvinen H; Porthan K; Schneider MJ; Hockings P; Shumbayawonda E; Banerjee R; Pepin K; Kalutkiewicz M; Ehman RL; Trylesinksi A; Coxson HO; ; Martic M; Yunis C; Tuthill T; Bossuyt PM; Anstee QM; Neubauer S; Harrison S
    Contemp Clin Trials; 2023 Nov; 134():107352. PubMed ID: 37802221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Accuracy and Clinical Relevance of the Multi-echo Dixon Technique for Evaluating Changes to Hepatic Steatosis in Patients with Non-alcoholic Fatty Liver Disease Treated with Formulated Food.
    Yang Y; Xu K; Chen X; Ding J; Shi J; Li J
    Magn Reson Med Sci; 2023 Apr; 22(2):263-271. PubMed ID: 35676065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: A prospective study.
    Brouha SS; Nguyen P; Bettencourt R; Sirlin CB; Loomba R
    Eur Radiol; 2018 Apr; 28(4):1345-1355. PubMed ID: 29058029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic accuracy of combined biomarker measurements and vibration-controlled transient elastography (VCTE) for predicting fibrosis stage of non-alcoholic fatty liver disease.
    Shima T; Sakai K; Oya H; Katayama T; Mitsumoto Y; Mizuno M; Kanbara Y; Okanoue T
    J Gastroenterol; 2020 Jan; 55(1):100-112. PubMed ID: 31538241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of hepatic steatosis using controlled attenuation parameter and MRI-derived proton density fat fraction in living donor liver transplantation.
    Zhuang RH; Weinstock AK; Ganesh S; Behari J; Malik SM; Bataller R; Furlan A; Hughes CB; Humar A; Duarte-Rojo A
    Clin Transplant; 2022 Nov; 36(11):e14786. PubMed ID: 35993599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease.
    Idilman IS; Keskin O; Celik A; Savas B; Elhan AH; Idilman R; Karcaaltincaba M
    Acta Radiol; 2016 Mar; 57(3):271-8. PubMed ID: 25855666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.